Pasithea Therapeutics Corp.
$0.56
-0.01 (-1.92%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +26.1%
- 3 Months
- -12.7%
- YTD
- -56.4%
- 1 Year
- -30.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 155.8%
- Largest decline max drawdown, since Aug 2025
- -69.8%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.34
Own KTTA?
See how KTTA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.